NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Abbott Laboratories (ABT) upgraded at Wells from Market Perform to Outperform, Wells Fargo said. Recent pullback has created an attractive entry point.
Advanced Micro downgraded at Bernstein to Market Perform, Bernstein said. $2.50 price target. Lack confidence that management can turn the business around in the near term.Ann Taylor (ANN) downgraded at Nomura from Buy to Neutral, Nomura said. $38 price target. Valuation call, as the stock is up 35% in the past two months. athenahealth (ATHN) downgraded at Jefferies to Underperform from Hold, Jefferies said. $60 price target. 3Q results miss. BroadSoft (BSFT) upgraded at Oppenheimer to Outperform from Perform, Oppenheimer said. $44 price target. Add core holding on recent weakness. Celanese (CE) rated new Neutral at JP Morgan. $38 price target. Profits are capable of rising with positive rates of change in Chinese economic growth. Chipotle Mexican Grill (CMG) downgraded at Wedbush to Neutral from Outperform, Wedbush said. $270 price target. No longer see upside even with lowered expectations. Cape Bancorp (CBNJ) upgraded to buy at TheStreet Ratings. DSW (DSW) rated new Neutral at Citigroup. $71 price target. Strong fundamentals, but valuation full. E*Trade Financial (ETFC) downgraded at Wells Fargo to Market Perform from Outperform, Wells Fargo said. $9 to $10 valuation range. EPS misses in noisy quarter. Syneron Medical (ELOS) downgraded to sell at TheStreet Ratings. Fifth Third (FITB - Get Report) downgraded at Compass Point from Buy to Neutral, Compass Point said. $16 price target. Company will struggle to grow revenue in a low interest rate environment. Guess (GES) rated new Underweight at Morgan Stanley. $21 price target. Company is using higher promotions and remains leveraged to lower sales in Europe. Google (GOOG) downgraded at Oppenheimer from Outperform, Oppenheimer said. $765 price target. Mobile device sales weighing on margins. Google downgraded at BofA/Merrill to Neutral, Bank of America/Merrill Lynch said. $745 price target. Estimates also cut, as the company is realizing lower margins. Huntington Bancshares (HBAN) upgraded at FBR to Market Perform from Underperform, FBR Capital Markets said. Valuation call, by the new analyst. $7.50 price target.